Skip to main content
. Author manuscript; available in PMC: 2008 Nov 6.
Published in final edited form as: Dent Clin North Am. 2005 Jul;49(3):551–vi. doi: 10.1016/j.cden.2005.03.009

Fig. 2.

Fig. 2

Futuristic chairside diagnostic test based on GCF sampling. Considering the GCF fluid as a potential analyte for the screening of multiple biomarkers, a rapid, chairside diagnostic tool (represented in the figure as a Micro Analyser) or a “mini-lab” could be used by clinicians for risk assessment and decision making on treatment planning. The advantages of such a tool would be enhanced predictability of clinical outcomes and well-informed patients regarding personalized treatment needs. As shown, a simple clinical procedure for GCF collection could be used, followed by extraction of analytes from the test strip. The fluid present on the test strip would be subjected to volumetric quantification. After an elution procedure to “wash” and retrieve the compounds from the fluid, the sample would be analyzed. An immediate comprehensive risk report profile and biomarkers screening would enable evidence-based decision making.